Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Senate committee hears bill to license 'experimental treatment' centers under Montana's right-to-try framework
Summary
A Senate Public Health Committee hearing on Senate Bill 535 drew industry proponents who said the bill would provide regulatory clarity for experimental treatment centers and medical innovators, and medical groups who said the bill is unclear and could weaken patient protections. No vote was taken.
The Montana Senate Public Health Committee opened a hearing March 28 on Senate Bill 535, legislation to create a licensing and oversight framework for so-called experimental treatment centers and to clarify elements of Montana's expanded medical "right to try."
Sponsor Sen. Ken Bogner, R-Miles City, told the committee the bill builds on last session’s SB 422 and aims to remove barriers that currently deter providers and companies from offering experimental or preventive therapies in Montana.
Supporters from the longevity and biotech industries described the bill as a practical regulatory path that would allow companies and providers to operate in Montana under clear standards. Jesse Luther, appearing for the Alliance for Longevity Initiatives, summarized the bill’s main elements, including a licensing process, patient requirements, and enhanced informed-consent procedures. "Healthcare professionals want to use expanded right to try, but feel just a little more…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
